Corresponding Author: Eric K. Chin, MD, Retina Consultants of Southern California, 1895 Orange Tree Ln, Ste 204, Redlands, CA 92374 (email@example.com).
Conflict of Interest Disclosures: Drs Almeida and Chin reported being cofounders of Citrus Therapeutics. Dr Almeida reported receiving honoraria from Allergan, Alcon, Genentech, and Novartis. Dr Chin reported receiving research funding from Opthea, Kodiak Sciences, IVERIC, Novartis, Bayer, Hexal AG/Sandoz Inc, Genentech, and Chendgu Kanghong Biotechnology. In addition, Drs Almeida and Chin reported having a patent pending for CTZ1 with Citrus Therapeutics. No other disclosures were reported.